zoonos
frequent
report
outbreak
highli
pathogen
influenza
viru
sever
acut
respiratori
syndrom
middl
east
respiratori
syndrom
occur
recent
africa
middl
east
southeast
asia
steril
use
chemic
reactor
plasma
assist
catalyt
technolog
pact
investig
test
carri
felin
caliciviru
fcv
vaccin
strain
surrog
airborn
pathogen
human
noroviru
result
show
pact
devic
could
inactiv
fcv
pass
plasma
chamber
steril
rate
may
detect
limit
result
indic
pact
may
effect
mean
inactiv
mani
virus
includ
human
noroviru
potenti
airborn
infecti
microorgan
airborn
infecti
diseas
sar
mycobacterium
tuberculosi
highli
pathogen
avian
influenza
seriou
threat
human
health
infect
individu
may
visit
health
care
institut
increas
chanc
infect
patient
health
care
worker
particular
infect
immunocompromis
person
lead
seriou
ill
possibl
death
infect
caus
mycobacterium
tuberculosi
measl
varicella
viru
spread
cough
sneez
infect
individu
scatter
droplet
dri
form
dri
droplet
nuclei
alon
adher
particl
air
infect
occur
inhal
droplet
nuclei
less
diamet
float
air
prolong
time
becom
wide
spread
airborn
infect
partial
depend
concentr
infecti
pathogen
air
vapor
materi
infect
person
vomit
may
also
result
airborn
infect
typic
pathogen
transmit
airborn
infect
noroviru
case
infect
air
condition
day
process
vomit
noroviru
infect
person
report
therefor
comprehens
remov
airborn
infecti
pathogen
desir
human
anim
health
care
share
space
develop
effect
steril
ventil
system
necessari
although
filtrat
heat
ventil
air
condit
hvac
system
control
pathogen
effect
steril
air
possibl
pathogen
releas
filter
accordingli
plasma
assist
catalyt
technolog
pact
novel
chemic
reactor
decompos
variou
hazard
gase
includ
volatil
organ
compound
voc
promis
candid
effect
steril
pact
principl
demonstr
synergist
effect
plasma
excit
catalyt
activ
pact
devic
function
part
product
ozon
oxygen
radic
pact
may
expect
steril
airborn
viru
effici
convent
steril
method
nm
diamet
viru
use
studi
vaccin
strain
crandel
ree
felin
kidney
crfk
cell
use
cultur
measur
viru
cell
cultur
eagl
mem
nissui
tokyo
japan
contain
fetal
bovin
serum
nichirei
bioscienc
inc
tokyo
japan
tryptos
phosphat
broth
bd
bioscienc
spark
md
usa
antibiot
uml
penicillin
streptomycin
configur
air
treatment
experiment
system
pact
devic
shown
fig
aerosol
ga
pass
plasma
space
gap
mm
high
voltag
kv
peak
peak
khz
appli
gap
creat
plasma
excit
zone
plasma
form
stabl
barrier
discharg
test
method
shown
fig
doi
fcv
strain
spray
nebul
omron
kyoto
japan
min
chamber
approxim
l
volum
place
safeti
chamber
viru
pass
plasma
space
pact
devic
residu
viral
particl
captur
gelatin
film
filter
set
air
sampler
airscan
sartoriu
german
captur
viru
suspend
ml
cultur
medium
measur
tissu
cultur
infecti
dose
tcid
method
optim
test
investig
chang
air
flow
rate
appli
voltag
pact
devic
amount
fcv
strain
depend
steril
efficaci
flow
rate
power
pact
devic
determin
flow
rate
investig
spray
fcv
min
period
viru
captur
gelatin
film
filter
min
load
w
pact
devic
pact
devic
nonoper
mean
titer
viru
recov
min
ticd
respect
fig
differ
found
amount
viru
recov
min
higher
nearli
time
lower
min
pact
reduc
recov
viru
titer
min
detect
limit
mean
titer
min
tcid
respect
pact
therefor
achiev
steril
effect
tcid
min
respect
fig
pact
found
abl
steril
air
virtual
instantan
passag
plasma
zone
effici
depend
flow
rate
aerosol
contain
fcv
strain
influenc
input
power
pact
devic
investig
rang
w
mean
recov
viru
titer
tcid
min
recov
viru
titer
lower
detect
limit
w
mean
titer
w
tcid
respect
fig
reduct
viru
titer
present
fig
effect
amplifi
input
power
pact
devic
increas
pact
develop
air
purif
techniqu
exampl
shown
effect
remov
toxic
substanc
cigarett
smoke
also
recent
util
inactiv
bioaerosol
employ
plasma
technolog
investig
whether
pact
virucid
effect
airborn
infecti
viru
found
aerosol
fcv
inactiv
pact
fcv
titer
could
reduc
detect
limit
depend
condit
paper
term
steril
viru
mean
includ
remov
inactiv
viru
variou
method
exist
steril
atmospher
main
mechan
employ
electr
discharg
plasma
photocatalysi
ozon
gener
includ
oxygen
radic
etc
peptid
bond
protein
compon
cell
wall
bacteria
fungi
damag
breakag
displac
cell
may
inactiv
ito
report
oxygen
relat
radic
nonequilibrium
atmospher
pressur
plasma
import
mechan
inactiv
fungu
spore
murray
et
al
report
plasma
domin
factor
inactiv
variou
type
viru
util
steril
bioaerosol
appli
plasma
technolog
mechan
bacteri
inactiv
plasma
damag
bacteri
cell
wall
leakag
cytoplasm
reactiv
oxygen
enter
pathogen
cell
bacterium
fungu
virion
injuri
case
pact
devic
plasma
radiat
gener
nonequilibrium
condit
plasma
defin
higher
temperatur
movabl
electron
ev
lower
temperatur
ga
k
increas
temperatur
pact
devic
oper
may
therefor
significantli
affect
variou
chemic
reaction
pact
devic
may
expect
steril
air
contain
viru
bacteria
fungi
hospit
clinic
might
caus
nosocomi
infect
nishimura
evalu
commerci
avail
air
cleaner
report
almost
ineffect
inactiv
airborn
influenza
viru
real
life
situat
recircul
ambient
space
contrast
result
use
pact
carri
use
singl
pass
ambient
air
control
experiment
apparatu
consequ
studi
need
evalu
virucid
effect
pact
devic
real
life
situat
need
scale
experi
replic
condit
live
space
measur
relationship
flow
effici
larger
plenum
chamber
conclus
pact
devic
inactiv
fcv
pass
plasma
space
form
electrod
gap
steril
effici
depend
upon
ga
flow
rate
input
power
pact
devic
fcv
viru
classifi
nonenvelop
positivestrand
rna
without
envelop
viru
test
result
expect
relev
similar
virus
human
noroviru
variou
type
viru
might
inactiv
plasma
domin
mechan
virus
like
sar
mer
influenza
viru
envelop
singlestrand
rna
virus
addit
pact
may
appli
steril
bacteria
fungi
well
conclus
pact
may
particularli
well
suit
effect
develop
gener
pathogen
buster
effect
countermeasur
zoonos
acknowledg
author
thank
mr
n
uchiyama
effort
prepar
origin
design
pact
devic
also
thank
mr
k
ohnuki
instruct
suggest
research
support
match
planner
program
japan
scienc
technolog
agenc
jst
